Introducing… The Newly Redesigned RS 3400 The world’s premier blood irradiator just raised the bar on dose uniformity, productivity and throughput. Beautiful. Simple. Easy to use.
The Premier Blood Irradiator in the World
Over 20 years ago, we pioneered the first-ever FDA-cleared blood x-ray irradiation medical device used to prevent TA-GVHD, and we have maintained our status as the industry leader and gold-standard in blood irradiation technology and instrumentation ever since. Our patented x-ray irradiation technology effectively and routinely inactivates the immune cells in donor blood, which diminishes the risk of developing TA-GVHD for the transfusion recipient.
Patented Quastar® Photonic Decontamination™ Technology
The Newly Redesigned RS 3400 is a registered medical device with a US FDA 510(k). It is produced and tested in Rad Source’s Buford Georgia, USA facility. Rad Source products conform to the radiation safety guidelines found in 21 CFR 1020.40. Radiation safety features of the RS 3400 include redundant safety interlocks to prevent intrusion into the radiation chamber while in operation. The unit is a Cabinet X-Ray System that has external emissions far below the Federal Standard for such devices.
Highest Product Throughput and Volume Available
Processes a variety of blood configurations of up to 6L capacity in 5 minutes – whole blood bags, platelet bags and loaded syringes in the same cycle.
Excellent Dose Uniformity
Combination of the patented Quastar® x-ray emitter, rotating carousel, and new canister with Support Inserts may achieve as low as 1.6~1.35 DUR.
Direct Replacement for Gamma Irradiator
U.S. Government recognized safe, direct alternative – for radioactive isotope (gamma) source irradiators.
*RS 3400 is 21-FDA cleared and CE marked.
RS 3400 Series
- The Newly Redesigned RS 3400 is a registered medical device with a US FDA 510(k).
- It is produced and tested in Rad Source’s Buford Georgia, USA facility.
- Rad Source products conform to the radiation safety guidelines found in 21 CFR 1020.40.
Latest News & Studies
Thiol/Redox Metabolomic Profiling Implicates GSH Dysregulation in Early Experimental Graft versus Host Disease (GVHD)
Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation (BMT). Upregulation of inflammatory cytokines precedes the clinical presentation of GVHD and predicts its severity. In this...
Kishor Mehta, Andrew Parker Insect Pest Control Laboratory, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency, Vienna, Austria Received 19 February 2010; Accepted 22 August...
While gamma rays have been a reliable source, the isotopes, primarily cobalt-60 and cesium-137, used to generate these gamma rays have come under heavy scrutiny worldwide in recent years. To quote the abstract of a recent...